Company profile: Vial
1.1 - Company Overview
Company description
- Provider of advanced programs for clinics to conduct lower-cost trials, specializing in computationally designed therapeutics and leveraging technology to automate clinical trials.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Vial
Evolution Research Group
HQ: United States
Website
- Description: Provider of independent clinical research site services in the U.S.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evolution Research Group company profile →
Gentronix
HQ: United Kingdom
Website
- Description: Provider of regulatory genotoxicity studies (GLP Ames, mouse lymphoma, in vitro micronucleus), predictive genotoxicity screening to detect liability early, skin toxicology assays for corrosion, irritation and sensitisation, and flow cytometry services. Includes Ames MPF/II and 24-well Agar formats requiring low test item amounts. Supports drug development and chemicals in cosmetics, personal care, and other chemistry driven industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gentronix company profile →
Halo Pharma
HQ: United States
Website
- Description: Provider of contract dosage form development, manufacturing, and testing services to the pharmaceutical, biotechnology, and generic industries. Services include product development to commercial manufacturing; formulation and analytical development; clinical manufacturing and packaging; solid dosage production (tablets, capsules, powders, granules, micro-tablets, multi-particulates), and clinical supplies for liquids, suspensions, and powder-in-bottle.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Halo Pharma company profile →
Biomind Labs
HQ: Canada
Website
- Description: Provider of pharmaceutical development for neurological and psychiatric disorders, advancing candidates including BMND01 for treatment-resistant depression, BMND03 for addictive disorders, BMND07 for major depressive disorder, BMND09 for Parkinson’s disease, BMND08 for depression and anxiety in Alzheimer’s disease, and Triptax™, a new chemical entity for treatment-resistant depression with FDA IND clearance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biomind Labs company profile →
Aster Insights
HQ: United States
Website
- Description: Provider of oncology bioinformatics solutions delivering clinical and molecular data and analytics tools for precision oncology research. Products include Aster Avatar (multimodal dataset with longitudinal clinical and genomic analyses), Aster Galaxy (standardized data library), Aster Navigator (analytics with insights from AI models), Aster Constellation (precision oncology registries and clinical trial matching), and Total Cancer Care®.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aster Insights company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Vial
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vial
2.2 - Growth funds investing in similar companies to Vial
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Vial
4.2 - Public trading comparable groups for Vial
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →